BUY Balmer Lawrie & Company Limited — Deven Mehata, IDBI Capital Markets and Securities
byDeven Mehata, IDBI Capital Markets and SecuritiesHorizon: NA (inferred Swing (≤2wk))11 Nov 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·14 Nov · today
Past week's volume 5.3× the 30-day average
Technicals · volume·13 Nov · yesterday
Balmer Lawrie reported Q2 FY27 results with net income of Rs 818.04 crore (up 26.34% YoY) and net profit of Rs 67.66 crore (up 39.56% YoY).
BSE · Company Update·2 Nov · 2w ago
RSI at 76 — overbought territory
Technicals · rsi·14 Nov · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Balmer Lawrie & Company
- BUY — Kunal Bothra22 Sept 2026 · ~2 weeks · target ₹180 · Expired
- BUY — Sandeep Jain, Tradeswift24 Aug 2026 · ~2 weeks · target ₹190 · Expired
- BUY — Vaishali Parekh, Prabhudas Lilladher20 Jul 2026 · Same day · target ₹182 · Expired
More from Deven Mehata, IDBI Capital Markets and Securities
- BUY Waaree Energies11 Nov 2026 · ~2 weeks · target ₹2,750 · Active
- BUY Central Depository Services (India)9 Nov 2026 · ~2 weeks · target ₹1,420 · Target hit
- BUY Alkem Laboratories9 Nov 2026 · ~2 weeks · target ₹5,730 · Active
- BUY Onesource Specialty Pharma9 Nov 2026 · ~2 weeks · target ₹1,765 · Active
- BUY Tata Elxsi6 Nov 2026 · ~2 weeks · target ₹4,235 · Active

